ESPERITE (ESP) negotiates 18-month extension for EUR 4,750,000 in unsecured convertible loan notes
Amsterdam, The Netherlands – 14 June 2019
read more
ESPERITE (ESP) resumes negotiations regarding proposed sale of stem cell banking business to PBKM
Amsterdam, The Netherlands – 13 June 2019
read more
Esperite NV (ESP) introduces Jouvene – Swiss Medicine Quintessence, the first combined offer of Stem Cells long term storage and highly accurate Whole Genome Sequencing for Consumer distribution.
Amsterdam, The Netherlands – 04 June 2019
read more
ESPERITE (ESP) announces termination of MoU regarding proposed sale of stem cell banking business to PBKM due to lack of agreement on the terms of the sale
Amsterdam, The Netherlands – 29 May 2019
read more
ESPERITE (ESP) announces listing measure by Euronext due to delay in publication of its 2018 annual report (as announced on 30 April 2019)
Amsterdam, The Netherlands – 19 May 2019
read more
Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2018 and The Cell Factory current configuration.
Amsterdam, The Netherlands – 13 May 2019
read more
Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2018.
Amsterdam, The Netherlands – 30 April 2019
read more
ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund
Amsterdam, The Netherlands – 05 April 2019
read more
CF-MEV-132 drug candidate belongs to the CF-MEV family of anti-inflammatory EV drugs produced by The Cell Factory
Amsterdam, The Netherlands – 27 February 2019
read more
ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund
Amsterdam, The Netherlands – 26 February 2019
read more
